Role of cyclic GMP in nitrous-oxide-induced anxiolytic-like behavior in the mouse light-dark exploration test

Behavioral Neuroscience

Volumn 118, Issue 3, 2004, Pages 648-652

  Li, Shuang ^a,b   Chung, Eunhee ^a   Quock, Raymond M ^a,b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Nursing and Allied Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; CYCLIC GMP PHOSPHODIESTERASE; GUANYLATE CYCLASE; NITROUS OXIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DARKNESS; EXPLORATORY BEHAVIOR; MALE; MOUSE; NEUROMODULATION; NONHUMAN; SIGNAL TRANSDUCTION;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; EXPLORATORY BEHAVIOR; MALE; MICE; NITROUS OXIDE; OXADIAZOLES; PERIODICITY; PHOSPHODIESTERASE INHIBITORS; PURINONES; QUINOXALINES;

EID: 2542493079     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.118.3.648     Document Type: Article

References (38)

1. Baretta, I. P., Assreuy, J., & De Lima, T. C. M. (2001). Nitric oxide involvement in the anxiogenic-like effect of substance P. Behavioural Brain Research, 121, 199-205.
2. Beavo, J. A. (1995). Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiological Reviews, 75, 725-745.
3. Bourin, M., Nic Dhonnchadha, B. A., Colombel, M. C., Dib, M., & Hascoët, M. (2001). Cyamemazine as an anxiolytic drug on the elevated plus maze and light/dark paradigm in mice. Behavioural Brain Research, 124, 87-95.
4. Caton, P. W., Tousman, S. A., & Quock, R. M. (1994). Involvement of nitric oxide in nitrous oxide anxiolysis in the elevated plus maze. Pharmacology Biochemistry and Behavior, 48, 689-692.
5. Chaki, S., Ogawa, S., Toda, Y., Funakoshi, T., & Okuyama, S. (2003). Involvement of the melanocortin MC4 receptor in stress-related behavior in rodents. European Journal of Pharmacology, 474, 95-101.
6. Crawley, J., & Goodwin, F. K. (1980). Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacology Biochemistry and Behavior, 13, 167-170.
7. Czech, D. A., Jacobson, E. B., LeSueur-Reed, K. T., & Kazel, M. R. (2003). Putative anxiety-linked effects of the nitric oxide synthase inhibitor L-NAME in three murine exploratory behavior models. Pharmacology Biochemistry and Behavior, 75, 741-748.
8. Denninger, J. W., & Marletta, M. A. (1999). Guanylate cyclase and the NO/cGMP signaling pathway. Biochimica et Biophysica Acta - Bioenergetics, 1411, 334-350.
9. Dunn, R. W., Reed, T. A., Copeland, P. D., & Frye, C. A. (1998). The nitric oxide synthase inhibitor 7-nitroindazole displays enhanced anxiolytic efficacy without tolerance in rats following subchronic administration. Neuropharmacology, 37, 899-904.
10. Erdemli, G., & Krnjevic, K. (1995). Nitric oxide tonically depresses a voltage- and Ca-dependent outward current in hippocampal slices. Neuroscience Letters, 201, 57-60.
11. Faria, M. S., Muscará, M. N., Moreno, H., Jr., Teizeira, S. A., Dias, H. B., De Oliveira, B., et al. (1997). Acute inhibition of nitric oxide synthesis induces anxiolysis in the plus maze test. European Journal of Pharmacology, 323, 37-43.
12. Garthwaite, J., Southam, E., Boulton, C. L., Nielsen, E. B., Schmidt, K., & Mayer, B. (1995). Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Molecular Pharmacology, 48, 184-188.
13. Gibson, A. (2001). Phosphodiesterase 5 inhibitors and nitrergic transmision - From Zaprinast to Sildenafil. European Journal of Pharmacology, 411, 1-10.
14. Hascoët, M., Bourin, M., & Nic Dhonnchadha, B. A. (2001). The mouse light-dark paradigm: A review. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 25, 141-166.
15. Holy, Z., & Wisniewski, K. (1998). Effects of sulfated cholecystokinin octapeptide and cholecysto-kinin tetrapeptide in rat behavior after blockade of nitric oxide synthase by L-NAME. Roczniki Akademii Medycznej w Bialym, 43, 250-270.
16. Hynes, M. D., & Berkowitz, B. A. (1979). Nitrous oxide stimulation of locomotor activity: Evidence for an opiate-like behavioral effect. Journal of Pharmacology and Experimental Therapeutics, 209, 304-308.
17. Li, S., Dai, Y., & Quock, R. M. (2003). Antisense knockdown of neuronal nitric oxide synthase antagonizes nitrous oxide-induced behavior. Brain Research, 968, 167-170.
18. Li, S., Ohgami, Y., Dai, Y., & Quock, R. M.(2003). Antagonism of nitrous oxide-induced anxiolytic-like behavior in the mouse light/dark exploration procedure by pharmacologic disruption of endogenous nitric oxide function. Psychopharmacology, 166, 366-372.
19. 2O-induced behaviors in the light/dark exploration test. Pharmacology Biochemistry and Behavior, 68, 789-796.
20. Li, S., & Quock, R. M. (2002). Effects of a nitric oxide donor on behavior and interaction with nitrous oxide in the mouse light/dark exploration test. European Journal of Pharmacology, 447, 75-78.
21. Lino de Oliveira, C., Del-Bel, E. A., & Guimarães, F. S. (1997). Effects of L-NOARG on plus-maze performance in rats. Pharmacology Biochemistry and Behavior, 56, 55-59.
22. McMahon, D. G., & Ponomareva, L. V. (1996). Nitric oxide and cGMP modulate retinal glutamate receptors. Journal of Neurophysiology, 76, 2307-2315.
23. Monzon, M. E., Varas, M. M., & De Barioglio, S. R. (2001). Anxiogenesis induced by nitric oxide synthase inhibition and anxiolytic effect of melanin-concentrating hormone (MCH) in rat brain. Peptides, 22, 1043-1047.
24. O'Donnell, J. M., & Frith, S. (1999). Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases. Pharmacology Biochemistry and Behavior, 63, 185-192.
25. Pineda, J., Kogan, J. H., & Aghajanian, G. K. (1996). Nitric oxide and carbon monoxide activate locus coeruleus neurons through a cGMP-dependent protein kinase: Involvement of a nonselective cationic channel. Journal of Neuroscience, 16, 1389-1399.
26. Pokk, P., & Vali, M. (2002a). Effects of nitric oxide synthase inhibitors 7-NI, L-NAME, and L-NOARG in staircase test. Archives of Medical Research, 33, 265-268.
27. Pokk, P., & Vali, M. (2002b). The effects of the nitric oxide synthase inhibitors on the behaviour of small-platform-stressed mice in the plusmaze test. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 26, 241-247.
28. Prast, H., & Philippu, A. (2001). Nitric oxide as modulator of neuronal function. Progress in Neurobiology, 64, 51-68.
29. Pyne, N. J., Arshvsky, V., & Lochhead, A. (1996). cGMP signal termination. Biochemical Society Transactions, 24, 1019-1022.
30. Sethy, V. H., & Oien, T. T. (1991). Role of cGMP in the mechanism of anxiolytic activity of U-78875. Pharmacology Biochemistry and Behavior, 39, 379-382.
31. Vale, A. L., Green, S., Montgomery, A. M., & Shafi, S. (1998). The nitric oxide synthesis inhibitor L-NAME produces anxiogenic-like effects in the rat elevated plus-maze test, but not in the social interaction test. Journal of Psychopharmacology, 12, 268-272.
32. Volke, V., Kõks, S., Vasar, E., Bourin, M., Bradwejn, J., & Männistö, P. T. (1995). Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus maze. NeuroReport, 6, 1285-1288.
33. Volke, V., Soosaar, A., Kõks, S., Bourin, M., Männistö, P. T., & Vasar, E. (1997). 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety. Psychopharmacology, 131, 399-405.
34. Volke, V., Wegener, G., Bourin, M., & Vasar, E. (2003). Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice. Behavioral Brain Research, 140, 141-147.
35. Volke, V., Wegener, G., Vasar, E., & Rosenberg, R. (1999). Methylene blue inhibits hippocampal nitric oxide synthase activity in vivo. Brain Research, 826, 303-305.
36. Yildiz, F., Ulak, G., Erden, B. F., & Gacar, N. (2000). Anxiolytic-like effects of 7-nitroindazole in the rat plus-maze test. Pharmacology Biochemistry and Behavior, 65, 199-202.
37. A receptors. Neuroscience Letters, 180, 239-242.
38. Zingarelli, B., Hasko, G., Salzman, A. L., & Szabo, C. (1999). Effects of a novel guanylyl cyclase inhibitor on the vascular actions of nitric oxide and peroxynitrite in immunostimulated smooth muscle cells and in endotoxic shock. Critical Care Medicine, 27, 1701-1707.